Overexpression of HGF and/or MET in brain-tumor-derived cells enhances their tumorigenicity and growth, and inhibition of HGF or Met in experimental tumor xenografts suppresses tumor growth and angiogenesis [16,17,18,19]. The gene discussed is MET; the disease is neoplasm.